drugset / Trial / NCT06445374

Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges

NCT06445374

Phase 1 Completed 21 enrolled Dr. George Luciuk
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this exploratory study is to evaluate the effects of inhaled epinephrine in patients with known or suspected metabisulfite sensitivity who experience a systemic allergic reaction (SAR) while undergoing allergy testing, immunotherapy or oral challenges.

Timeline

Start
2024-07-15
Primary completion
2025-04-08
Completion
2025-04-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.125 mg Inhaled

Indications